Evidence map›Paper›PMID 30984307›Full record

ArticleDisease markers2019

Associations of Common Variants in

Violeta Dopsaj, Aleksandra Topić, Miljan Savković, Neda Milinković, Ivana Novaković, Danica Ćujić, Sanja Simić-Ogrizović

Abstract read
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Violeta DopsajDepartment of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Belgrade 11221, Serbia.ORCID 0000-0001-8310-6254
Aleksandra TopićDepartment of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Belgrade 11221, Serbia.ORCID 0000-0001-5618-752X
Miljan SavkovićCenter of Medical Biochemistry, Clinical Center of Serbia, Belgrade 11000, Serbia.ORCID 0000-0001-7920-090X
Neda MilinkovićDepartment of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Belgrade 11221, Serbia.ORCID 0000-0002-2641-9817
Ivana NovakovićInstitute of Human Genetics, Medical Faculty, University of Belgrade, Belgrade 11010, Serbia.ORCID 0000-0003-0202-0673
Danica ĆujićDepartment of Biology of Reproduction, Institute for the Application of Nuclear Energy (INEP), University of Belgrade, Belgrade 11080, Serbia.ORCID 0000-0002-6145-3850
Sanja Simić-OgrizovićClinic of Nephrology, Clinical Center of Serbia, Belgrade 11000, Serbia.ORCID 0000-0003-2989-2922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfluence of MATERIALS AND

methodsIron status parameters and genetic analysis were performed in 126 ESRD patients and in 31 IDA patients as the control group.

resultsESRD patients had significantly higher ferritin and hepcidin-25 (<0.001) relative to IDA patients. Cut-off values with the best diagnostic accuracy were found for hepcidin ≥9.32 ng/mL, ferritin ≥48.2

conclusionOur findings could contribute to the further investigation of mechanisms involved in the pathophysiology and important gender-related involvement of the

Indexed as

Polymorphism, Single NucleotideAdultAgedAnemia, Iron-DeficiencyFemaleFerritinsHemochromatosis ProteinHepcidinsHumansIronKidney Failure, ChronicMaleMembrane ProteinsMiddle AgedSerine EndopeptidasesTransferrinFerritinsHemochromatosis ProteinHepcidinsHFE protein, humanIronMembrane ProteinsSerine EndopeptidasesTMPRSS6 protein, humanTransferrin

Identifiers

PMID30984307
PMCPMC6431474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.